InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,713.64
(
1.70%
)
US TECH 100
19,317.20
(
2.44%
)
Dow Jones
42,025.19
(
1.26%
)
Brent Oil
74.32
(
2.68%
)
Bitcoin
63,007.05
(
2.17%
)
Post# of 27676
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

tibt913

Send PM Follow Ignore
Followers 13
Posts 577
Boards Moderated 0
Alias Born 01/23/2014

tibt913

Re: None

Friday, 05/19/2017 12:54:29 AM

Friday, May 19, 2017 12:54:29 AM

Post# of 27676
http://www.richpharmaceuticals.com/wp-content/uploads/2013/09/pipeline1-e1396027308835.jpg
This platform drug as shown promise for the treatment of Acute Myeloid Leukemia. Formally known as TPA, this platform small molecule has many potential therapeutic uses. Rich Pharmaceuticals is exploring multiple indications for the highest likelihood of commercialization success that has the potential to become new compelling treatments for patients.

Clinical program trial on phase 2 did u guys notice last month
They were at phase 1 ...looks to like they r on right track and
Then add to this http://www.canncodex.com/ I see major violent
Move upward in the coming days....$$$$
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up